Furosemide Infusion in Children
For pediatric furosemide infusions, start with a 1-2 mg/kg IV loading bolus followed by a continuous infusion at 0.2 mg/kg/hour, adjusting every 12 hours based on urine output targets of 3-4 mL/kg/hour, with a maximum infusion rate not exceeding 4 mg/min for high-dose therapy. 1, 2, 3
Initial Dosing Strategy
The FDA-approved starting point for pediatric furosemide is 1 mg/kg IV given slowly, with incremental increases of 1 mg/kg every 2 hours until desired effect, not exceeding 6 mg/kg total 1. However, for continuous infusions specifically, the evidence strongly supports a more aggressive initial approach:
- Loading dose: 1-2 mg/kg IV bolus 2, 3
- Continuous infusion: Start at 0.2 mg/kg/hour (NOT the commonly used 0.1 mg/kg/hour) 2, 3, 4
- Timing: Begin continuous infusion 6 hours after the initial bolus 2
The rationale for this higher starting dose comes from modeling studies and clinical trials showing that the traditional 0.1 mg/kg/hour starting rate frequently requires upward titration to 0.2 mg/kg/hour within 24 hours in the majority of patients 4, 5. Starting at the higher dose achieves target urine output faster without increasing toxicity 3.
Infusion Rate and Administration
Critical administration parameters:
- Maximum infusion rate: 4 mg/min for high-dose therapy 1
- IV push rate: 1-2 minutes for bolus doses 1
- pH requirements: Must maintain pH >5.5; furosemide precipitates below pH 7 1
- Incompatibilities: Never mix with acidic solutions (labetalol, ciprofloxacin, amrinone, milrinone) 1
For preparation, add furosemide to normal saline, lactated Ringer's, or D5W after pH adjustment to above 5.5 1.
Titration Protocol
Adjust the infusion every 12 hours in 0.1 mg/kg/hour increments based on clinical response 2:
- Target urine output: 3-4 mL/kg/hour for post-cardiac surgery patients 2, 3
- For ECMO patients: Target 6 mL/kg/hour (though this may require lower doses than initially anticipated) 6
- Hemodynamically unstable infants: The 0.2 mg/kg/hour starting dose is safe and effective even in this high-risk population 3, 4
Studies demonstrate that target urine output is typically achieved within 6-24 hours using this protocol 2, 3. The mean doses stabilize around 0.22-0.25 mg/kg/hour over 72 hours without development of tolerance 3.
Age-Specific Considerations
Premature infants: Maximum dose should not exceed 1 mg/kg/day 1. The evidence for continuous infusions in this population is limited, and the risk-benefit ratio must be carefully considered given increased electrolyte disturbances 7.
Infants <1 year post-cardiac surgery: This population has the strongest evidence base for the aggressive continuous infusion protocol described above 2, 3, 4.
Monitoring Requirements
Essential monitoring parameters:
- Serum electrolytes: Check potassium, sodium, chloride at baseline and every 12-24 hours 1, 7
- Renal function: Monitor creatinine clearance; furosemide excretion is inversely related to serum creatinine 4
- Urine output: Measure hourly 2, 3
- Furosemide levels: Keep below ototoxic threshold (generally <25 mcg/mL) 3, 4
- Hemodynamics: Monitor blood pressure and heart rate continuously 3
Critical Pitfalls to Avoid
Electrolyte derangements: Furosemide causes significant hypokalemia, hyponatremia, and hypochloremia 8, 5, 7. Continuous infusion causes less sodium and chloride loss compared to intermittent bolusing (0.20 vs 0.29 mmol/kg/day for sodium) 5, making it the preferred method.
Starting too low: The traditional 0.1 mg/kg/hour starting dose is suboptimal and leads to delayed achievement of target urine output 4. Nine of 12 hemodynamically unstable patients required escalation to 0.2 mg/kg/hour by day 2 4.
Precipitation risk: Furosemide is highly alkaline (pH ~9) and will precipitate in acidic solutions. Never add to running lines containing acidic medications 1.
Ototoxicity: While rare at therapeutic doses, monitor for hearing changes. Studies using the 0.2 mg/kg/hour protocol showed no toxic serum concentrations over 72 hours 3, 4.
Advantages of Continuous vs. Intermittent Dosing
Continuous infusion is superior to intermittent bolusing 5:
- Lower total daily dose required (4.90 vs 6.23 mg/kg/day) 5
- More controlled and predictable urine output 5
- Less urinary sodium and chloride loss 5
- Reduced variability in diuretic response 5
The pharmacodynamic rationale is that continuous delivery maintains steady furosemide concentrations at the loop of Henle, optimizing diuretic efficiency without the peaks and troughs of intermittent dosing.